Mcrae Capital Management Inc Vertex Pharmaceuticals Inc Transaction History

Mcrae Capital Management Inc

$480 Million
Q4 2024

A detailed history of Mcrae Capital Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mcrae Capital Management Inc holds 31,078 shares of VRTX stock, worth $14.1 Million. This represents 2.6% of its overall portfolio holdings.

Number of Shares

31,078

Previous 31,880 2.52%

Holding current value

$14.1 Million

Previous $14.8 Million 15.59%

% of portfolio

2.6%

Previous 3.05%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$396.64 - $516.74 $318,105 - $414,425	-802 Reduced 2.52%	31,078 $12.5 Million
Q3 2024 Oct 24, 2024	SELL	$460.0 - $505.78 $754,400 - $829,479	-1,640 Reduced 4.89%	31,880 $14.8 Million
Q2 2024 Jul 24, 2024	SELL	$392.81 - $485.53 $164,980 - $203,922	-420 Reduced 1.24%	33,520 $15.7 Million
Q1 2024 Apr 18, 2024	SELL	$407.69 - $446.08 $320,036 - $350,172	-785 Reduced 2.26%	33,940 $14.2 Million
Q4 2023 Jan 22, 2024	SELL	$343.0 - $410.68 $186,249 - $222,999	-543 Reduced 1.54%	34,725 $14.1 Million
Q3 2023 Oct 17, 2023	SELL	$338.18 - $362.46 $105,512 - $113,087	-312 Reduced 0.88%	35,268 $12.3 Million
Q2 2023 Jul 21, 2023	BUY	$314.42 - $351.91 $72,631 - $81,291	231 Added 0.65%	35,580 $12.5 Million
Q1 2023 Apr 19, 2023	SELL	$283.23 - $323.1 $116,124 - $132,471	-410 Reduced 1.15%	35,349 $11.1 Million
Q4 2022 Jan 20, 2023	SELL	$285.76 - $321.48 $173,170 - $194,816	-606 Reduced 1.67%	35,759 $0
Q3 2022 Oct 20, 2022	SELL	$273.83 - $305.53 $35,597 - $39,718	-130 Reduced 0.36%	36,365 $10.5 Million
Q2 2022 Jul 20, 2022	BUY	$234.96 - $292.55 $1.88 Million - $2.34 Million	7,995 Added 28.05%	36,495 $10.3 Million
Q1 2022 Apr 21, 2022	BUY	$221.42 - $260.97 $6.31 Million - $7.44 Million	28,500 New	28,500 $7.44 Million

Others Institutions Holding VRTX

# of Institutions

1,728

Shares Held

223M

Call Options Held

1.65M

Put Options Held

1.38M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcrae Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcrae Capital Management Inc with notifications on news.

Account

Mcrae Capital Management Inc Vertex Pharmaceuticals Inc Transaction History